Atlas Trials

DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC

Clinical trial NCT04967482 · UNKNOWN

Trial details

NCT number
NCT04967482
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2021-07-09
Primary completion
2024-07-08
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.